The impacts of the novel coronavirus have had lasting repercussions on all industries, especially for those centered around innovation, R&D and the business of bringing new products to market. For technology transfer offices (TTOs), these impacts have been far-reaching, and include everything from researchers pivoting their research to focus on COVID-19, to rapid collaborations with companies, streamlined licensing and pledges to make certain technologies available free of charge. COVID-19 has ushered in a new era of operations for TTOs, but of the number of changes to emerge this year, which will remain post-pandemic?
This webinar brings together industry experts from healthcare, technology and academia for lively discussions, debate and networking. During one hour we discussed about the key pivots the tech transfer industry has had to make this year, with a focus on the industries and partners that have been impacted the most.